New and Simple Test for Active Tuberculosis Now Possible

Sep 14, 2006

Tuberculosis (TB) is the number one cause of death by infection in the world today killing about two million people. Yet most deaths from TB are easily preventable by early diagnosis and treatment.

Many clinicians still rely on a diagnostic test that is over 100 years old. In research published in the Lancet today, Scientists at St George’s, University of London have come up with a new way of detecting TB using unique biomarkers. The test is 94% accurate and can be developed into a simple serum test.

Professor Sanjeev Krishna in the Centre for Infection and his team, in collaboration with the National Institute of Medical Research (UK), have been able to identify a complex signature in serum unique to TB that is not present in samples from other infections and lung diseases. Researchers were able to detect this unique signature using a mass spectrometer called a SELDI (surface-enhanced laser desorption and ionization time-of-flight spectrometer). They then used this signature to work out a simpler way to diagnose TB.

Currently, the diagnosis of TB involves looking at sputum with a microscope, which is often the only affordable and available test, but only achieves a sensitivity of 40 – 60% under field conditions. Sputum culture, which takes between 2 – 6 weeks to produce a result, is not routinely carried out in countries with a high prevalence of TB but helps to improve diagnostic yield. The key to reducing death rates in patients with TB, and to stopping transmission in resource poor countries, is to diagnose and start treatment in the first visit to the clinic.

Professor Sanjeev Krishna “We are putting forward a completely fresh approach to look at an ancient problem. I think it is going to be very exciting to make this work in clinics where a test for TB is desperately needed. The next stage will be to use the biomarkers we have identified to develop a cheap, accurate and rapid diagnostic test that can be used easily and quickly out in the field.”

Source: St George's Hospital Medical School

Explore further: Flu winds down as FDA aims for better vaccine next winter

add to favorites email to friend print save as pdf

Related Stories

Solving an organic semiconductor mystery

Jan 16, 2015

Organic semiconductors are prized for light emitting diodes (LEDs), field effect transistors (FETs) and photovoltaic cells. As they can be printed from solution, they provide a highly scalable, cost-effective ...

For sea turtles, there's no place like magnetic home

Jan 15, 2015

Adult sea turtles find their way back to the beaches where they hatched by seeking out unique magnetic signatures along the coast, according to new evidence from the University of North Carolina at Chapel ...

Recommended for you

No new Ebola cases in Liberia last week: WHO

41 minutes ago

Ebola-ravaged Liberia has for the first time since last May gone a full week without reporting any new confirmed cases of the devastating virus, according to World Health Organization data.

DR Congo cholera cases top 1,500, 35 dead: UN

17 hours ago

A cholera outbreak in the Democratic Republic of Congo has infected 1,500 people and caused 35 deaths in less than two months, the United Nations said on Wednesday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.